Related Experiment Video

Updated: Jun 25, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis

C A C Hyde1, S Missailidis

  • 1Department of Chemistry and Analytical Sciences, The Open University, Walton Hall, Milton Keynes, MK5 7AS, UK.

International Immunopharmacology
|February 26, 2009
PubMed

Insights

Arachidonic acid (AA) cascade inhibitors, like COX inhibitors, show promise in cancer prevention and treatment by targeting cell proliferation and angiogenesis. Omega-3 fatty acids also demonstrate protective effects against cancer development.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Arachidonic acid (AA) and its metabolites play a crucial role in cancer biology.
  • Inhibitors of the AA cascade, particularly COX inhibitors, are gaining attention for cancer treatment.
  • The precise molecular mechanisms linking AA metabolites to cancer progression require further elucidation.

Purpose of the Study:

  • To provide an overview of the AA cascade and its inhibitors in cancer treatment.
  • To focus on the inhibition of cell proliferation and neo-angiogenesis by targeting enzymes like COX-2, 5-LOX, and CYP450.
  • To review the downstream effects of AA metabolite inhibition and the mechanisms of action of selected inhibitors.

Main Methods:

  • Review of existing literature on the arachidonic acid cascade and its role in cancer.
  • Analysis of molecular mechanisms underlying the inhibition of key enzymes (COX-2, 5-LOX, CYP450).
  • Examination of the effects of AA metabolite inhibition on cancer cell proliferation and angiogenesis.
  • Review of the protective mechanisms of dietary omega-3 fatty acids.

Main Results:

  • Inhibitors targeting enzymes in the AA cascade, such as COX-2, 5-LOX, and CYP450, can inhibit cancer cell proliferation and neo-angiogenesis.
  • Downstream effects of inhibiting AA metabolites contribute to potential anti-cancer activities.
  • Dietary omega-3 fatty acids show potential in reducing cancer risk and impeding tumor growth.

Conclusions:

  • Inhibitors of the AA cascade represent a promising therapeutic strategy for cancer chemoprevention and treatment.
  • Understanding the complex interactions within the AA cascade is vital for developing novel anti-cancer approaches.
  • Omega-3 fatty acids offer a protective role in inflammation and tumor prevention, warranting further investigation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...